Legend Biotech Corp ADR (LEGN)
Industry Biotechnology
This stock can be held in an Investment Account
Sell
$34.40
Buy
$34.80
$-1.78 (-4.95%)
Prices updated at 04 Jun 2026, 22:48 EDT
| Prices minimum 15 mins delay
Prices in USD
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen recep ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 60.34 |
| 2024 | 62.60 |
| 2023 | 49.42 |
| 2022 | 44.14 |
| 2021 | 100.00 |
| 2020 | 100.00 |
| 2019 | - |
| 2018 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2026 | 5.83 |
| 2025 | 4.40 |
| 2024 | 11.41 |
| 2023 | 44.32 |
| 2022 | 55.86 |
| 2021 | 69.88 |
| 2020 | 68.92 |
Price/Forward earnings (YTD)
238.10
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | -17.44 |
| 2024 | -10.06 |
| 2023 | -32.60 |
| 2022 | -36.43 |
| 2021 | -43.83 |
| 2020 | -52.76 |
| 2019 | -37.10 |
| 2018 | -0.65 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 1.73 |
| 2024 | 1.61 |
| 2023 | 1.48 |
| 2022 | 1.79 |
| 2021 | 1.46 |
| 2020 | 1.21 |
| 2019 | - |
| 2018 | 49.61 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
